Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00485173 · ClinicalTrials.gov registry record · NA

INFUSE® Bone Graft/ PEEK Interbody Spacer/ Anterior Cervical Plate Pivotal Clinical Trial

A NA study of Degenerative Disc Disease, sponsored by Medtronic Spinal and Biologics.

Completed
Registry status
NA
Development phase
224
Enrollment target
16
Study locations

NCT00485173 is a NA study of Degenerative Disc Disease that has completed, run by Medtronic Spinal and Biologics. The registered enrollment target is 224 participants, above the 163-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (37% higher). The trial reports 16 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00485173, a NA study of Degenerative Disc Disease, has completed, sponsored by Medtronic Spinal and Biologics.

COMPLETED
Registry status
NA
Development phase
224 participants
Enrollment target
16
Study locations

Study Summary

The purpose of this study is to evaluate the safety and effectiveness of the investigational implant (INFUSE® Bone Graft/PEEK Interbody Spacer/Anterior Cervical Plate) as a method of facilitating spinal fusion at a single level from C3-C7 in patients with symptomatic cervical degenerative disc disease.

Conditions Studied

Degenerative Disc Disease

Interventions

  • DEVICE INFUSE® Bone Graft/PEEK Spacer/Anterior Cervical Plate

Study Locations (16)

California

  • S & B Surgery Center - Beverly Hills
  • Orange County Neurological Association - Laguna Hills

Ohio

  • University of Cincinnati Dept of Neurosurgery - Cincinnati
  • TriState Orthopedic Treatment Center - Norwood

Tennessee

  • Center for Sports Medcine & Orthopedics - Chattanooga
  • Semmes Murphey Neurologic & Spine Institute - Memphis

Texas

  • Central Texas Spine - Austin
  • Brain and Spine Center of Texas, L.L.P. - Plano

Florida

  • Crane Creek Medical Ctr. The Back Center /Osler Medical - Melbourne

Georgia

  • The Hughston Clinic, P.C. - Columbus

Kansas

  • University of Kansas Medcal Center - Kansas City

Louisiana

  • Spine Institute - Shreveport

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2007-06
Est. Completion 2012-06
Phase NA

Sponsor

Medtronic Spinal and Biologics

26 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00485173

The ClinicalTrials.gov registry entry for NCT00485173 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 163-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (37% higher). The listed sponsor is Medtronic Spinal and Biologics, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which INFUSE® Bone Graft/PEEK Spacer/Anterior Cervical Plate is the first listed.

NCT00485173 reports 16 study locations spanning 12 distinct geographic areas - top geographies include California, Ohio, Tennessee.

Frequently Asked Questions

What is clinical trial NCT00485173 about?

NCT00485173 is a clinical study titled "INFUSE® Bone Graft/ PEEK Interbody Spacer/ Anterior Cervical Plate Pivotal Clinical Trial". The purpose of this study is to evaluate the safety and effectiveness of the investigational implant (INFUSE® Bone Graft/PEEK Interbody Spacer/Anterior Cervical Plate) as a method of facilitating spinal fusion at a single level from C3-C7 in patients with symptomatic cervical degenerative disc disea...

What is the current status of trial NCT00485173?

This trial is currently completed. It is a NA study. The enrollment target is 224 participants. The study started on 2007-06. Estimated completion is 2012-06.

What conditions does trial NCT00485173 study?

This clinical trial studies the following conditions: Degenerative Disc Disease.

What interventions are being tested in trial NCT00485173?

The interventions under investigation include: INFUSE® Bone Graft/PEEK Spacer/Anterior Cervical Plate (DEVICE).

Who is sponsoring clinical trial NCT00485173?

This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00485173 being conducted?

This trial has 16 study locations across California, Florida, Georgia, Kansas, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Degenerative Disc Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Degenerative Disc Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.